EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cardiac amyloidosis

Natallia Laptseva, Dominik C Benz, Rahel Schwotzer, Andreas J Flammer

Swiss Medical Weekly · 2024

DOI: 10.57187/s.4186 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Swiss Medical Weekly, 2024. Verfasst von Natallia Laptseva und 3 weiteren Autor:innen. Beteiligte Einrichtung: Amyloidosis Network Zurich, University Hospital Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Amyloidosis, Echocardiography. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiac amyloidosis is a disease characterised by the accumulation of amyloid protein in the heart tissue. There are several types of amyloidosis, but the most common types affecting the heart are ATTR amyloidosis (caused by transthyretin protein) and AL amyloidosis (caused by abnormal immunoglobulin light chains). Cardiac amyloidosis causes typical signs and symptoms of heart failure. Diagnosis involves a combination of imaging tests such as echocardiography and cardiac magnetic resonance imaging, as well as nuclear imaging scans and tissue biopsies to confirm the presence of amyloid deposits in the heart. Treatment of cardiac amyloidosis depends on the type and severity of the disease and includes medications to manage symptoms as well as treatments targeting the underlying cause of amyloidosis. Importantly, cardiac amyloidosis is a serious condition requiring specialised care from a multidisciplinary team including cardiologists and haematologists as well as other specialists familiar with the management of this rare disease. This is crucial, as early diagnosis and treatment are important for improving outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmyloidosisEchocardiographyHumansMagnetic Resonance ImagingCardiomyopathiesHeart FailureAmyloid Neuropathies, FamilialBiopsyImmunoglobulin Light-chain AmyloidosisPrealbumin

Substanzen

Prealbumin

Autor:innen und Institutionen

  • Amyloidosis Network Zurich, University Hospital Zurich, Zurich, Switzerland.
  • University Heart Center, University Hospital Zurich, Zurich, Switzerland.
  • Cardiac Imaging, Department of Nuclear Medicine, University Hospital of Zurich, Zurich, Switzerland.
  • Hematology and Oncology, University Hospital Zurich, Zurich, Switzerland.

Zitieren

APA

Laptseva, N., Benz, D. C., Schwotzer, R., & Flammer, A. J. (2024). Cardiac amyloidosis. Swiss Medical Weekly. https://doi.org/10.57187/s.4186

Vancouver

Laptseva N, Benz DC, Schwotzer R, Flammer AJ. Cardiac amyloidosis. Swiss Medical Weekly. 2024. doi:10.57187/s.4186

BibTeX
@article{Laptseva2024,
  author = {Laptseva, Natallia and Benz, Dominik C and Schwotzer, Rahel and Flammer, Andreas J},
  title = {Cardiac amyloidosis},
  journal = {Swiss Medical Weekly},
  year = {2024},
  doi = {10.57187/s.4186}
}
Kostenlos starten →